European Commission

Showing 15 posts of 91 posts found.

Novartis image

Novartis gets FDA approval for psoriasis drug

January 22, 2015
Sales and Marketing Cosentyx, European Commission, FDA, Novartis, Secukinumab, psoriasis

The US Food and Drug Administration (FDA) has shown Novartis’ skin condition drug Cosentyx the green light to treat patients …

Lilly image

Lilly and Boehringer diabetes biosimilar sees EU approval

September 11, 2014
Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly

Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …

servier image

Servier fined €331m by European Commission

July 10, 2014
Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva

The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …

Antonio Tajani

Can Europe really agree to speed up pricing and reimbursement?

March 6, 2012
Sales and Marketing Europe, European Commission, GSK, Sir Andrew Witty, pricing and reimbursement

The European Commission has called for faster decisions to allow new medicines to enter the market faster.The Commission says the …

Misinformation charges against Servier dropped

January 30, 2012
Sales and Marketing European Commission, Servier, anti-competitive behaviour

The European Commission has dropped a case against Servier in which the French manufacturer was accused of providing misleading information.The …

Europe’s €80 billion will support research

December 2, 2011
Research and Development, Sales and Marketing European Commission

The European Commission has created a new €80 billion budget in an effort to encourage research and innovation across the …

Roche's Avastin (bevacizumab)

Avastin’s breast cancer use to continue in Europe

March 2, 2011
Sales and Marketing CHMP, Cancer, European Commission, Roche, avastin, bevacizumab, breast cancer, docetaxel, paclitaxel

Roche’s Avastin will remain on the market as a treatment for breast cancer, but only in combination with paclitaxel, the …

European Commission launches new generic deal review

January 18, 2011
Sales and Marketing European Commission, anti-trust investigation, competition, generics

The European Commission has asked a number of firms to submit copies of their patent settlements in 2010 to see …

EU flag

EU regulators launch fresh raids on pharma

December 7, 2010
Sales and Marketing AstraZeneca, European Commission, Losec, Nexium, Nycomed, Pantazol, Ratiopharm, antitrust investigation, esomeprazole, pantoprazole

Competition regulators from the EU have raided offices of AstraZeneca and Nycomed in connection with alleged attempts to block generic …

European Parliament

Europe tightens patient information proposals

November 25, 2010
Medical Communications, Sales and Marketing European Commission, European Parliament, dtc, patient information

European restrictions on patient access to medicines information are still on track to be relaxed, but the proposed changes have …

Blog footer

Digital Pharma: E-Health and the European agenda

November 19, 2010
Medical Communications Digital Agenda, Digital Pharma blog, EC, European Commission, Neelie Kroes, digital patients, e-health, electronic patient records

The European Commission wants all European patients to be given secure online access to their medical records by 2015 and …

European Commission eyes pharma ethics

September 27, 2010
Research and Development, Sales and Marketing European Commission, corporate responsibility, ethics

The European Commission is to examine corporate responsibility in the pharmaceutical industry with the aim of developing a series of …

European Commission invests €6.4 billion in research

July 21, 2010
Research and Development European Commission, research

The European Commission has announced a €6.4 billion investment in research and innovation in a range of scientific disciplines including …

European scrutiny of pharma patent deals to continue

July 6, 2010
Sales and Marketing European Commission, competition, patents

Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …

Commission probes Lundbeck on alleged generic blocking

January 18, 2010
Sales and Marketing European Commission, Lundbeck, generics, kroes

The European Commission has confirmed it is to investigate Lundbeck for alleged anti-competitive behaviour relating to its anti-depressant Cipramil. The …

The Gateway to Local Adoption Series

Latest content